Skeletal muscle Sirt3 expression and mitochondrial respiration are regulated by a prenatal low-protein diet

Journal of Nutritional Biochemistry

Volumn 26, Issue 2, 2015, Pages 184-189

  Claycombe, Kate J ^a   Roemmich, James N ^a   Johnson, LuAnn ^a   Vomhof DeKrey, Emilie E ^a   Johnson, W Thomas ^a  

^a GRAND FORKS HUMAN NUTRITION RESEARCH CENTER   (United States)

Author keywords

Maternal low protein diet; Mitochondria; SDH; SIRT3; Skeletal muscle respiration

Indexed keywords

CYTOCHROME C OXIDASE; LYSINE; MESSENGER RNA; NUCLEAR RESPIRATORY FACTOR 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SIRTUIN 3; SUCCINATE DEHYDROGENASE; UNCOUPLING PROTEIN 1; PROTEIN SUBUNIT;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATCH UP GROWTH; CONTROLLED STUDY; FEMALE; FETUS GROWTH; LIPID DIET; MALE; MALNUTRITION; MATERNAL NUTRITION; MITOCHONDRIAL RESPIRATION; MUSCLE MITOCHONDRION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXYGEN CONSUMPTION; PRENATAL PERIOD; PROGENY; PROTEIN ACETYLATION; PROTEIN EXPRESSION; PROTEIN RESTRICTION; RAT; REGULATORY MECHANISM; RISK ASSESSMENT; SKELETAL MUSCLE; THERMOGENESIS; ACETYLATION; ADVERSE EFFECTS; ANIMAL; DIABETES MELLITUS, TYPE 2; DISEASE PREDISPOSITION; DOWN REGULATION; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; NEWBORN; PATHOLOGY; PREGNANCY; PROTEIN PROCESSING; PROTEIN SUBUNIT; SPRAGUE DAWLEY RAT;

RATTUS;

ACETYLATION; ANIMALS; ANIMALS, NEWBORN; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; DIET, PROTEIN-RESTRICTED; DISEASE SUSCEPTIBILITY; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MALE; MATERNAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; MITOCHONDRIA, MUSCLE; MUSCLE, SKELETAL; PREGNANCY; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN SUBUNITS; RATS, SPRAGUE-DAWLEY; SIRTUIN 3; SUCCINATE DEHYDROGENASE;

EID: 84921044434     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2014.10.003     Document Type: Article

References (39)

1. Zeng Y., Gu P., Liu K., Huang P. Maternal protein restriction in rats leads to reduced PGC-1alpha expression via altered DNA methylation in skeletal muscle. Mol Med Rep 2013, 7:306-312.
2. Cianfarani S., Agostoni C., Bedogni G., Berni Canani R., Brambilla P., Nobili V., et al. Effect of intrauterine growth retardation on liver and long-term metabolic risk. Int J Obes (Lond) 2012, 36:1270-1277.
3. Lesage J., Del-Favero F., Leonhardt M., Louvart H., Maccari S., Vieau D., et al. Prenatal stress induces intrauterine growth restriction and programmes glucose intolerance and feeding behaviour disturbances in the aged rat. J Endocrinol 2004, 181:291-296.
4. Martin-Gronert M.S., Ozanne S.E. Experimental IUGR and later diabetes. J Intern Med 2007, 261:437-452.
5. Schwitzgebel V.M., Somm E., Klee P. Modeling intrauterine growth retardation in rodents: impact on pancreas development and glucose homeostasis. Mol Cell Endocrinol 2009, 304:78-83.
6. Claycombe K.J., Uthus E.O., Roemmich J.N., Johnson L.K., Johnson W.T. Prenatal low-protein and postnatal high-fat diets induce rapid adipose tissue growth by inducing Igf2 expression in Sprague Dawley rat offspring. J Nutr 2013, 143:1533-1539.
7. Lowell B.B., Shulman G.I. Mitochondrial dysfunction and type 2 diabetes. Science 2005, 307:384-387.
8. DeFronzo R.A., Tripathy D. Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care 2009, 32(Suppl. 2):S157-S163.
9. Szendroedi J., Phielix E., Roden M. The role of mitochondria in insulin resistance and type 2 diabetes mellitus. Nat Rev Endocrinol 2012, 8:92-103.
10. Pagel-Langenickel I., Bao J., Pang L., Sack M.N. The role of mitochondria in the pathophysiology of skeletal muscle insulin resistance. Endocr Rev 2010, 31:25-51.
11. Schrauwen-Hinderling V.B., Roden M., Kooi M.E., Hesselink M.K., Schrauwen P. Muscular mitochondrial dysfunction and type 2 diabetes mellitus. Curr Opin Clin Nutr Metab Care 2007, 10:698-703.
12. Petersen K.F., Dufour S., Befroy D., Garcia R., Shulman G.I. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 2004, 350:664-671.
13. Green M.F., Hirschey M.D. SIRT3 weighs heavily in the metabolic balance: a new role for SIRT3 in metabolic syndrome. J Gerontol A Biol Sci Med Sci 2013, 68:105-107.
14. Hirschey M.D., Shimazu T., Jing E., Grueter C.A., Collins A.M., Aouizerat B., et al. SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome. Mol Cell 2011, 44:177-190.
15. Shi T., Wang F., Stieren E., Tong Q. SIRT3, a mitochondrial sirtuin deacetylase, regulates mitochondrial function and thermogenesis in brown adipocytes. J Biol Chem 2005, 280:13560-13567.
16. Yang Y., Cimen H., Han M.J., Shi T., Deng J.H., Koc H., et al. NAD+-dependent deacetylase SIRT3 regulates mitochondrial protein synthesis by deacetylation of the ribosomal protein MRPL10. J Biol Chem 2010, 285:7417-7429.
17. Bao J., Lu Z., Joseph J.J., Carabenciov D., Dimond C.C., Pang L., et al. Characterization of the murine SIRT3 mitochondrial localization sequence and comparison of mitochondrial enrichment and deacetylase activity of long and short SIRT3 isoforms. J Cell Biochem 2010, 110:238-247.
18. Fritz K.S., Galligan J.J., Hirschey M.D., Verdin E., Petersen D.R. Mitochondrial acetylome analysis in a mouse model of alcohol-induced liver injury utilizing SIRT3 knockout mice. J Proteome Res 2012, 11:1633-1643.
19. Cimen H., Han M.J., Yang Y., Tong Q., Koc H., Koc E.C. Regulation of succinate dehydrogenase activity by SIRT3 in mammalian mitochondria. Biochemistry 2010, 49:304-311.
20. Kim S.C., Sprung R., Chen Y., Xu Y., Ball H., Pei J., et al. Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol Cell 2006, 23:607-618.
21. Reeves P.G., Nielsen F.H., Fahey G.C. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993, 123:1939-1951.
22. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
23. Nicklas J.A., Brooks E.M., Hunter T.C., Single R., Branda R.F. Development of a quantitative PCR (TaqMan) assay for relative mitochondrial DNA copy number and the common mitochondrial DNA deletion in the rat. Environ Mol Mutagen 2004, 44:313-320.
24. van den Ouweland J.M., Lemkes H.H., Ruitenbeek W., Sandkuijl L.A., de Vijlder M.F., Struyvenberg P.A., et al. Mutation in mitochondrial tRNA(Leu)(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat Genet 1992, 1:368-371.
25. Kelley D.E., He J., Menshikova E.V., Ritov V.B. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 2002, 51:2944-2950.
26. Lim J.H., Lee J.I., Suh Y.H., Kim W., Song J.H., Jung M.H. Mitochondrial dysfunction induces aberrant insulin signalling and glucose utilisation in murine C2C12 myotube cells. Diabetologia 2006, 49:1924-1936.
27. Hoeks J., van Herpen N.A., Mensink M., Moonen-Kornips E., van Beurden D., Hesselink M.K., et al. Prolonged fasting identifies skeletal muscle mitochondrial dysfunction as consequence rather than cause of human insulin resistance. Diabetes 2010, 59:2117-2125.
28. Itani S.I., Ruderman N.B., Schmieder F., Boden G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 2002, 51:2005-2011.
29. Yu C., Chen Y., Cline G.W., Zhang D., Zong H., Wang Y., et al. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 2002, 277:50230-50236.
30. Elbein S.C., Rasouli N. Intermuscular lipid: a marker of disordered fat partitioning or the consequence of obesity?. Am J Clin Nutr 2008, 87:1585-1586.
31. Miljkovic-Gacic I., Gordon C.L., Goodpaster B.H., Bunker C.H., Patrick A.L., Kuller L.H., et al. Adipose tissue infiltration in skeletal muscle: age patterns and association with diabetes among men of African ancestry. Am J Clin Nutr 2008, 87:1590-1595.
32. Miljkovic-Gacic I., Wang X., Kammerer C.M., Gordon C.L., Bunker C.H., Kuller L.H., et al. Fat infiltration in muscle: new evidence for familial clustering and associations with diabetes. Obesity (Silver Spring) 2008, 16:1854-1860.
33. Jing E., Emanuelli B., Hirschey M.D., Boucher J., Lee K.Y., Lombard D., et al. Sirtuin-3 (Sirt3) regulates skeletal muscle metabolism and insulin signaling via altered mitochondrial oxidation and reactive oxygen species production. Proc Natl Acad Sci U S A 2011, 108:14608-14613.
34. Nogueiras R., Habegger K.M., Chaudhary N., Finan B., Banks A.S., Dietrich M.O., et al. Sirtuin 1 and sirtuin 3: physiological modulators of metabolism. Physiol Rev 2012, 92:1479-1514.
35. Kitada M., Kume S., Kanasaki K., Takeda-Watanabe A., Koya D. Sirtuins as possible drug targets in type 2 diabetes. Curr Drug Targets 2013, 14:622-636.
36. Boyle K.E., Newsom S.A., Janssen R.C., Lappas M., Friedman J.E. Skeletal muscle MnSOD, mitochondrial complex II, and SIRT3 enzyme activities are decreased in maternal obesity during human pregnancy and gestational diabetes mellitus. J Clin Endocrinol Metab 2013, 98:E1601-E1609.
37. Jing E., O'Neill B.T., Rardin M.J., Kleinridders A., Ilkeyeva O.R., Ussar S., et al. Sirt3 regulates metabolic flexibility of skeletal muscle through reversible enzymatic deacetylation. Diabetes 2013, 62:3404-3417.
38. Sugden M.C., Holness M.J. Recent advances in mechanisms regulating glucose oxidation at the level of the pyruvate dehydrogenase complex by PDKs. Am J Physiol Endocrinol Metab 2003, 284:E855-E862.
39. Lombard D.B., Alt F.W., Cheng H.L., Bunkenborg J., Streeper R.S., Mostoslavsky R., et al. Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation. Mol Cell Biol 2007, 27:8807-8814.